Medicine and Dentistry
Malignant Neoplasm
100%
Female Genital Tract Cancer
100%
PARP Inhibitor
100%
RNA Helicase
100%
Endometrial Cancer
75%
PARP1
75%
Ovarian Cancer
50%
BRCA1
50%
Niraparib
50%
Breast Cancer
25%
Lethality
25%
Cancer Cell
25%
Prognostic Factor
25%
Biological Marker
25%
Nucleolus
25%
Cancer Growth
25%
DNA Repair
25%
Cell Mutant
25%
Nucleoplasm
25%
Translation (Protein Synthesis)
25%
Biogenesis
25%
Ribosome
25%
Ribosome DNA
25%
Keyphrases
Gynecological Cancer
100%
Survival Outcomes
100%
Nucleolar Localization Signal (NoLS)
100%
RNA Helicase
100%
DDX21
100%
PARP Inhibitor (PARPi)
87%
BRCA1, BRCA2
25%
Endometrial Cancer
25%
Niraparib
25%
Breast Cancer
12%
Mechanism of Action
12%
Cancer Cells
12%
Prognostic Factors
12%
Patient Outcomes
12%
Patient Samples
12%
Cancer Patients
12%
Ovarian Cancer
12%
Protein Translation
12%
Cancer Types
12%
Clinical Evidence
12%
Ovarian Cancer Cells
12%
Cancer Therapeutics
12%
RNA Transcription
12%
DNA Repair Defect
12%
Nucleolus
12%
Cancer Cell Growth
12%
Nucleolar
12%
Mutant Cells
12%
Synthetic Lethality
12%
Nucleoplasm
12%
Ribosome Biogenesis
12%
Endometrial Cancer Cells
12%
Biochemistry, Genetics and Molecular Biology
RNA Helicase
100%
DDX21
100%
Poly ADP Ribose Polymerase
50%
PARP1
37%
Cancer Cell
25%
BRCA1
25%
Transcription
12%
DNA Repair
12%
Cell Growth
12%
Translation (Protein Synthesis)
12%
Cell Mutant
12%
Nucleoplasm
12%
Nucleolus
12%
Ribosome Biogenesis
12%